4.8 Article

FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia

Journal

CANCER CELL
Volume 12, Issue 4, Pages 367-380

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2007.08.031

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. Medical Research Council [G116/187] Funding Source: Medline
  3. NCI NIH HHS [CA105423, P01 CA066996, P01 CA066996-100001, K08 CA113434-02, U01 CA105423, K08 CA113434-01A1, K08 CA113434, CA113434, CA66996] Funding Source: Medline
  4. PHS HHS [HHMI_GILLILAND_D] Funding Source: Medline
  5. MRC [G116/187] Funding Source: UKRI
  6. Medical Research Council [G116/187] Funding Source: researchfish

Ask authors/readers for more resources

Despite their known transforming properties, the effects of leukemogenic FLT3-ITD mutations on hematopoietic stem and multipotent progenitor cells and on hematopoietic differentiation are not well understood. We report a mouse model harboring an ITD in the murine Flt3 locus that develops myeloproliferative disease resembling CMML and further identified FLT3-ITD mutations in a subset of human CMML. These findings correlated with an increase in number, cell cycling, and survival of multipotent stem and progenitor cells in an ITD dose-dependent manner in animals that exhibited alterations within their myeloid progenitor compartments and a block in normal B cell development. This model provides insights into the consequences of constitutive signaling by an oncogenic tyrosine kinase on hematopoietic progenitor quiescence, function, and cell fate.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available